DeNovaMed

Manufacturing · Canada · 1-10 Employees

View Company Info for Free

Overview

Headquarters

5850 College St Ste 1a1, Halifax, Nova S...

Revenue

<$5 Million

Industry

Manufacturing Pharmaceuticals Business Services Research & Development
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1

About DeNovaMed

DeNovaMed is a leading innovator in the development of novel antibiotics aimed at combating tough bacterial infections, particularly those affecting diabetic patients. The company specializes in creating broad-spectrum antibiotics and targeted treatments for diabetic foot ulcers, leveraging advanced microbiology and drug design techniques. With a focus on addressing drug resistance and improving health outcomes, DeNovaMed's products include DNM0547 and DNM0904, which show promise against multidrug-resistant bacteria. Their ultimate goal is to enhance public health and provide effective solutions for complex bacterial infections.Explore more
DeNovaMed's Social MediaPopular SearchesDeNovaMed IncDeNovaMedSIC Code 28,283NAICS Code 32,325Show more

DeNovaMed Org Chart

Christopher McMaster, President & Chief Executive Officer at DeNovaMed
Canada flag for contact location.

President & Chief Executive Officer

PhoneEmail
PM
Canada flag for contact location.

Research Associate Biology Division

PhoneEmail

PhoneEmail
Get the full picture
Sign in to uncover key details.

Is DeNovaMed your ideal customer?

Let us give you the heads up on whether it's a good time to reach out

Recommended Actions

Compare Similar Companies to DeNovaMed

Compare insights from companies similar to DeNovaMed, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.

Company Name

Revenue

Number of Employees

Type

Funding

Founded In

Top Executive

DeNovaMed

<$5M
1-10
Private
-
-
Christopher McMaster, President & Chief Executive Officer at DeNovaMed
Christopher McMasterPresident & CEO
$6.6M
11-50
Private
-
-
DC
Dominique ChenevalPresident & Co-Founder
<$5M
11-50
Private
-
1999
<$5M
11-50
Private
-
2007
FD
François DeschampsCo-Owner, Vice President Business Development
<$5M
1-10
Private
-
-
N/A
<$5M
1-10
Private
-
2006
<$5M
1-10
Private
<$5M
2011
MH
Mario HuescaPresident & Chief Operating Officer & Director, Board
Illustration of an envelope

Company Profile Activity

i

Among all Manufacturing companies

Low Activity

High Activity

Activity Insights

DeNovaMed is experiencing very low activity levels compared to other companies in the Manufacturing sector.

What does this means?

DeNovaMed is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about DeNovaMed.

DeNovaMed Tech Stack

A closer look at the technologies used by DeNovaMed

Top Manufacturing Companies

Frequently Asked Questions Regarding DeNovaMed

What is DeNovaMed's official website?
DeNovaMed's official website is www.denovamed.com
What is DeNovaMed's Revenue?
DeNovaMed's revenue is <$5 Million
What is DeNovaMed's SIC code?
DeNovaMed's SIC: 28,283
What is DeNovaMed's NAICS code?
DeNovaMed's NAICS: 32,325
How many employees does DeNovaMed have?
DeNovaMed has 1-10 employees
What industry does DeNovaMed belong to?
DeNovaMed is in the industry of: Manufacturing, Pharmaceuticals, Business Services
What is DeNovaMed competition?
DeNovaMed top competitors include: ChemRoutes, ViroCarb, Zamboni Chem Solutions, Novation Pharmaceuticals
What technology does DeNovaMed use?
Some of the popular technologies that DeNovaMed uses are: WooCommerce, WordPress.org, Google Font API, Hostgator
What does DeNovaMed do?

DeNovaMed is a leading innovator in the development of novel antibiotics aimed at combating tough bacterial infections, particularly those affecting diabetic patients. The company specializes in creating broad-spectrum antibiotics and targeted treatments for diabetic foot ulcers, leveraging advanced microbiology and drug design techniques. With a f... ocus on addressing drug resistance and improving health outcomes, DeNovaMed's products include DNM0547 and DNM0904, which show promise against multidrug-resistant bacteria. Their ultimate goal is to enhance public health and provide effective solutions for complex bacterial infections.Read More

What are DeNovaMed social media links?
DeNovaMed Linkedin page
Is DeNovaMed a public company?
DeNovaMed is private company therefore does not currently have an official ticker symbol
See more information about DeNovaMed

Get Started with ZoomInfo

Register for free

Sign Up for Free

Get started for free! No credit card needed. Enjoy up to 25 free contacts each month at no cost.
Elevate your prospecting to the next level

Supercharge Your Prospecting

Search ZoomInfo's database of 106M+ companies and 140M+ professionals to find your next lead.
Expand your business

Grow Your Business

Reveal both personal and business contact details, including emails and phone numbers, and close your most valuable buyers.